Canton Strategic Holdings (CNTN) Income towards Parent Company (2021 - 2026)

Canton Strategic Holdings (CNTN) reported Income towards Parent Company of -$47.3 million for Q1 2026, down 1762.66% on a YoY basis from $2.8 million in Q1 2025, and down 1939.47% quarter-over-quarter from -$2.3 million in Q4 2025.

Canton Strategic Holdings (CNTN) Income towards Parent Company (2021 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Income towards Parent Company for 6 years, with the latest figure at -$47.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 1762.66% year-over-year to -$47.3 million; the trailing twelve-month figure through Mar 2026 stood at -$53.6 million (down 330.72% YoY), and the FY2025 full-year result was -$35.9 million, down 194.45% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$47.3 million, down from -$2.3 million in the prior quarter.
  • The five-year high for Income towards Parent Company was -$1.6 million in Q2 2022, with the low at -$47.3 million in Q1 2026.
  • Historically, Income towards Parent Company has averaged -$5.1 million across 5 years, with a median of -$2.3 million in 2024.
  • Annual changes were most pronounced in 2025 — Income towards Parent Company soared 44.63% — and 2026, when it slumped 1762.66%.
  • Canton Strategic Holdings' Income towards Parent Company stood at -$1.8 million in 2022, then tumbled by 40.74% to -$2.5 million in 2023, then slumped by 53.08% to -$3.8 million in 2024, then jumped by 38.7% to -$2.3 million in 2025, then plunged by 1939.47% to -$47.3 million in 2026.
  • The last three Income towards Parent Company figures came in at -$47.3 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -47.34 Mn
Dec 31, 2025 -2.32 Mn
Sep 30, 2025 -2.10 Mn
Jun 30, 2025 -1.86 Mn
Mar 31, 2025 -2.54 Mn
Dec 31, 2024 -3.79 Mn
Sep 30, 2024 -3.80 Mn
Jun 30, 2024 -2.33 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -1.82 Mn
Jun 30, 2023 -2.34 Mn
Mar 31, 2023 -2.69 Mn
Dec 31, 2022 -1.76 Mn
Sep 30, 2022 -2.13 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -2.95 Mn
Dec 31, 2021 -359,593.00
Sep 30, 2021 -777,113.00
Jun 30, 2021 -1.29 Mn